Showing results (1391-1400 of 2,693) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|October 3, 2025
Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settingsNicholas J White, James A Watson
The Lancet. Infectious Diseases|May 25, 2024
Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysisTiana Carina Schwab, Lisa Perrig, Pauline Carlotta Göller, et al.
The Lancet. Infectious Diseases|May 26, 2024
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial designJean-Michel Molina, Beatrice Bercot, Lambert Assoumou, et al.
The Lancet. Infectious Diseases|December 28, 2020
A decentralised point-of-care testing model to address inequities in the COVID-19 responseBelinda Hengel, Louise Causer, Susan Matthews, et al.
The Lancet. Infectious Diseases|December 28, 2020
Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling studyNicholas G Davies, Rosanna C Barnard, Christopher I Jarvis, et al.
The Lancet. Infectious Diseases|September 24, 2020
Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysisDaniel J Weiss, Amelia Bertozzi-Villa, Susan F Rumisha, et al.
The Lancet. Infectious Diseases|April 5, 2020
Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, ChinaRene Niehus, Pablo M De Salazar, Aimee R Taylor, et al.
The Lancet. Infectious Diseases|April 6, 2020
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling studyJuanjuan Zhang, Maria Litvinova, Wei Wang, et al.
The Lancet. Infectious Diseases|August 29, 2020
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trialShabir A Madhi, Eleonora Aml Mutsaerts, Alane Izu, et al.
The Lancet. Infectious Diseases|March 28, 2020
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyKelvin Kai-Wang To, Owen Tak-Yin Tsang, Wai-Shing Leung, et al.
Pageof 270